RECENT PUBLICATIONS

Liver Research Group

Alakkari A, Maguire D, Geoghegan J. Hegarty JE, Traynor O, Watson A, McCormick PA. Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation. Aliment Pharmacol Ther. 2011 Mar;33(3):615-6. PMID 21255044

Dring MM, Morrison Mh, McSharry BP, Guinan KJ, Hagan R, Irish HCV Research Consortium, O’Farrelly C, Gardiner CM. Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. Proc Nat Acad Sci USA 2011 Apr 5;108(14):5736-41. PMID 21402922

Kelleher D, Long A. Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion. Hepatology 2011 Jun;53(6):1846-53. PMID 21452285

Petrovic D, Stamataki Z, Dempsey E, Golden-Mason L, Freeley M, Doherty D, Prichard D, Keogh C, Conroy J, Mitchell S, Volkov Y, McKeating JA, O’Farrelly C,

Ryan EJ, Stevenson NJ, Hegarty JE, O’Farrelly C. Chronic hepatitis C infection blocks the ability of dendritic cells to secrete IFN-α and stimulate T-cell proliferation. J. Viral Hepat 2011 Dec;18(12):840-51. PMID 22093032

Ryan EJ, O’Farrelly C. The affect of chronic hepatitis C infection on dendritic cell function: a summary of the experimental evidence. J Viral Hepat 2011 Sep;18(9):601-7. PMID 21794024

Smith KJ, Norris S, O’Farrelly C, O’Mara SM. Risk factors for the development of depression in patients with hepatitis C taking interferon-α. Neuropsychiatr Dis Treat 2011;7:275-93 PMID 21654873

Stevenson NJ, Murphy AG, Bourke NM, Keogh CA, Hegarty JE, O’Farrelly C. Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV. PLoS One 2011;6(11):e27866. PMID 22114715